Johnson & Johnson · Health Care
JNJ
$253.04
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial...强生公司（J&J）是一家美国跨国制药、生物技术和医疗技术公司，总部位于新泽西州新不伦瑞克，在纽约证券交易所公开上市。其普通股是道琼斯工业平均指数的组成部分，该公司排名第。
Mixed profile混合特征
Mega cap超大盘
$610B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
The bottoming setup is not yet confirmed (price still below the 10-day average) and oscillators are already extended/ove筑底形态尚未确认（价格仍位于 10 日均线下方），且摆动指标已过热——此处入场风险较高。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Price Chart价格图表
Key Statistics关键统计
Price价格
$253.04
5.3% below 52-week high低于52周高点 5.3%
Market Cap市值
$610B
Normal volume正常成交量
P/E Ratio市盈率
22.8x
28.9x sector median
Forward P/E预测市盈率
19.7x
EPS每股收益 $11.12
Beta贝塔
-0.16
Moves about -0.2x the market波动幅度约为市场的 -0.2 倍
Dividend Yield股息收益率
2.12%
RSI (14)RSI（14）
55
Neutral zone中性区域
Next Earnings下次财报
2026-07-15 (-4d)
Volatility Rank波动率分位
100th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
1.1% of float
Performance价格表现
| Period周期 | JNJ | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -1.5% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | +8.0% | +0.6% | Beat the index by 7.4 points跑赢指数 7.4 个百分点 |
| 3 Months近3月 | +8.7% | +4.7% | Beat the index by 4.0 points跑赢指数 4.0 个百分点 |
| 6 Months近6月 | +17.0% | +7.8% | Beat the index by 9.2 points跑赢指数 9.2 个百分点 |
| Year to date年初至今 | +23.4% | +9.1% | Beat the index by 14.3 points跑赢指数 14.3 个百分点 |
| 1 Year近1年 | +59.1% | +19.4% | Beat the index by 39.7 points跑赢指数 39.7 个百分点 |
| 3 Years近3年 | +73.6% | +69.4% | Beat the index by 4.2 points跑赢指数 4.2 个百分点 |
| 5 Years近5年 | +73.3% | +83.9% | Lagged the index by 10.6 points落后指数 10.6 个百分点 |
Technicals技术面
Active signals活跃信号
MA Buy (21)Long-term Rising Trend1-Day Return (cross-sectional rank → top/bottom gainers)Valuation cheapness percentile (0–1, higher = cheaper vs peers)Insider Power (0–100) — quality-weighted Form-4 open-market trades (role × size × recency); 50 = neutral
RSI (14)RSI（14）
55
Neutral zone中性区域
vs 50-day相对50日均线
+6.2% vs 50-day avg
vs 200-day相对200日均线
+14.4% vs 200-day avg
Trend strength (ADX)趋势强度（ADX）
28
Trending趋势中
Volatility rank波动率分位
100th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$251.80
Don't chase above不追高于
$253.00
Stop止损
$228.40
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Post-earnings drift: -11.5% (20d)财报后漂移：-11.5%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | JNJ | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 22.75x | 28.92 | 68% |
| P/E (forward)市盈率（预测） | 19.7x | — | — |
| P/B市净率 | 7.48x | 3.52 | 17% |
| P/S市销率 | 6.47x | 3.02 | 21% |
| Earnings yield盈利收益率 | 4.40% | 2.72 | 76% |
| FCF yield自由现金流收益率 | 3.23% | 3.94 | 40% |
| Shareholder yield股东收益率 | 0.98% | 1.89 | 32% |
| P/FCF市值/自由现金流 | 30.96x | 22.42 | 31% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 2.7%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 14.9%
Free Cash Flow自由现金流
Margins利润率
32.9%Return on Equity股本回报率
13.5%Return on Assets资产回报率
Leverage杠杆
| Current ratio流动比率 | 1.03 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $6.0B |
| Stock-based comp股权薪酬 | $1.4B |
| Share count change (1y)股数变化（1年） | +0.1% |
Piotroski皮奥特罗斯基 3/8
Altman Z阿尔特曼Z: safe (4.8)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 36% of its sector on blended multiples综合估值倍数低于行业内 36% 的公司
Beta市场敏感度
-0.16×
0.21×3×
Has tended to move opposite the market (factor-adjusted)经因子调整后常与大盘反向波动
Financial Health财务健康
3/8
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
2.12%
Pays a dividend (2.12% yield)有分红（收益率 2.12%）
Why Is It Moving为何波动
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
JNJ daily MACD crossed downJNJ 日线MACD下穿
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±1.48%
Expected weekly move预期周波动
±3.30%
Call wall看涨密集区
$280
Put wall看跌密集区
$245
Gamma flip伽玛翻转
$230
25d risk reversal25d风险逆转
-0.1%
Flow资金流向
$14M premium traded; 0% 0DTE; 26 fresh positions; P/C 0.18; ~leans bullish (direction approx)成交权利金 $14M；0DTE占0%；26个新建仓；看跌看涨比 0.18；≈偏看涨（方向近似）
Skew: 偏斜：balanced
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$84.4M net (1 buyers, 7 sellers)-$84.4M 净值（1 买家，7 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Soros Fund Management | B | New position新建仓 | 0.1% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 14, 2026
JNJ daily MACD crossed downJNJ 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $253.85.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$253.85。
Jul 9, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jul 7, 2026
JNJ made a new 52-week highJNJ 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $267.24.价格创出52周新高 — 全市场关注的动量/趋势极值。$267.24。
Jul 7, 2026
JNJ RSI reached overboughtJNJ RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $267.24.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$267.24。
Jul 3, 2026
JNJ weekly MACD crossed upJNJ 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Jul 2, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 2, 2026
JNJ made a new 52-week highJNJ 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $263.04.价格创出52周新高 — 全市场关注的动量/趋势极值。$263.04。
Jul 2, 2026
JNJ RSI reached overboughtJNJ RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $263.04.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$263.04。
Jul 1, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jun 30, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Showing last 15 of显示最近15条，共 5110 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.07
Value价值
-0.7
Profitability盈利能力
+0.0
Quality质量
-0.2
Investment资本投入
-0.1
Shareholder payout股东回报
-0.8
Low volatility低波动
+1.4
Low market beta低市场敏感度
+1.3
Earnings quality盈利质量
-1.0
Short interest空头兴趣
+1.0
Company Profile公司档案
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial...强生公司（J&J）是一家美国跨国制药、生物技术和医疗技术公司，总部位于新泽西州新不伦瑞克，在纽约证券交易所公开上市。其普通股是道琼斯工业平均指数的组成部分，该公司排名第。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。